Journal article
Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group
Abstract
PURPOSE: To determine whether autologous (auto) or allogeneic (allo) stem-cell transplantation (SCT) improves outcome in patients with transformed follicular lymphoma compared with rituximab-containing chemotherapy alone.
PATIENTS AND METHODS: This was a multicenter cohort study of patients with follicular lymphoma and subsequent biopsy-proven aggressive histology transformation. Patient, treatment, and outcome data were collected from each …
Authors
Villa D; Crump M; Panzarella T; Savage KJ; Toze CL; Stewart DA; MacDonald DA; Buckstein R; Lee C; Alzahrani M
Journal
Journal of Clinical Oncology, Vol. 31, No. 9, pp. 1164–1171
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 20, 2013
DOI
10.1200/jco.2012.44.0693
ISSN
0732-183X
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdultAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsCell Transformation, NeoplasticCohort StudiesDisease-Free SurvivalFemaleHumansLymphoma, FollicularMaleMiddle AgedMultivariate AnalysisRituximabStem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTreatment Outcome